Italia markets closed

TEVA Sep 2024 8.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
6,260,00 (0,00%)
In data: 11:34AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente6,26
Aperto6,25
Denaro8,70
Domanda8,85
Prezzo d'esercizio8,00
Scadenza2024-09-20
Min-Max giorno6,25 - 6,26
Contratto - Min-MaxN/D
Volume10
Open Interest32
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.